{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:47:16Z","timestamp":1791010036373,"version":"4.1.0"},"reference-count":162,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000193","name":"International Development Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00022","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T04:50:40Z","timestamp":1548305440000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":269,"title":["Nanoparticle-Based Vaccines Against Respiratory Viruses"],"prefix":"10.3389","volume":"10","author":[{"given":"Soultan","family":"Al-Halifa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Arpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Bourgault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Archambault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"key":"B1","volume-title":"Top 10 Global Causes of Deaths","year":"2016"},{"key":"B2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3947\/ic.2014.46.2.67","article-title":"Etiology and clinical outcomes of acute respiratory virus infection in hospitalized adults","volume":"46","author":"Seo","year":"2014","journal-title":"Infect Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.coviro.2018.01.001","article-title":"Transmission routes of respiratory viruses among humans","volume":"28","author":"Kutter","year":"2018","journal-title":"Curr Opin Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0749-0720(15)30302-9","article-title":"Economic impact associated with respiratory disease in beef cattle","volume":"13","author":"Griffin","year":"1997","journal-title":"Vet Clin North Am Food Anim Pract."},{"key":"B5","first-page":"1095","article-title":"The epidemiology of bovine respiratory disease: what is the evidence for predisposing factors?","volume":"51","author":"Taylor","year":"2010","journal-title":"Can Veterinary J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fvets.2017.00189","article-title":"Market impacts of reducing the prevalence of bovine respiratory disease in united states beef cattle feedlots","volume":"4","author":"Johnson","year":"2017","journal-title":"Front Vet Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0031-3955(16)38876-9","article-title":"Viral respiratory infections","volume":"41","author":"Walker","year":"1994","journal-title":"Pediatr Clin North Am."},{"key":"B8","doi-asserted-by":"publisher","first-page":"S284","DOI":"10.1093\/cid\/cir043","article-title":"Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis","volume":"52","author":"Pavia","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B9","volume-title":"Influenza (Seasonal).","year":"2018"},{"key":"B10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1055\/s-0036-1584798","article-title":"Parainfluenza virus infection","volume":"37","author":"Branche","year":"2016","journal-title":"Semin Respir Crit Care Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S1473-3099(18)30292-5","article-title":"The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates","volume":"18","author":"Mazur","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s12519-013-0431-3","article-title":"Clinical characteristics of adenovirus associated lower respiratory tract infection in children","volume":"9","author":"Lu","year":"2013","journal-title":"World J Pediatr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S1473-3099(17)30396-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global burden of disease study 2015","volume":"17","author":"Collaborators","year":"2017","journal-title":"Lancet Infect Dis."},{"key":"B14","volume-title":"Smallpox and its Eradication","author":"Fenner","year":"1988"},{"key":"B15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fpubh.2015.00269","article-title":"Vaccines through centuries: major cornerstones of global health","volume":"3","author":"Hajj Hussein","year":"2015","journal-title":"Front Public Health"},{"key":"B16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1742-1241.1997.tb09640.x","article-title":"Immunogenicity and tolerability of a trivalent influenza subunit vaccine (Influvac) in high-risk children aged 6 months to 4 years","volume":"51","author":"Daubeney","year":"1997","journal-title":"Br J Clin Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.vaccine.2005.10.008","article-title":"Long-term clinical trial safety experience with the inactivated split influenza vaccine, Vaxigrip","volume":"24","author":"Delore","year":"2006","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"818","DOI":"10.15585\/mmwr.mm6430a3","article-title":"Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices, United States, 2015-16 influenza season","volume":"64","author":"Grohskopf","year":"2015","journal-title":"Morb Mortal Wkly Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist(R); Fluenz): a review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"B20","doi-asserted-by":"publisher","first-page":"A16","DOI":"10.1016\/j.vaccine.2011.04.119","article-title":"A pandemic influenza vaccine in India: from strain to sale within 12 months","volume":"29","author":"Dhere","year":"2011","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7150\/ntno.19796","article-title":"Nanoparticle vaccines adopting virus-like features for enhanced immune potentiation","volume":"1","author":"Chattopadhyay","year":"2017","journal-title":"Nanotheranostics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/vaccines4020012","article-title":"Recent advances in subunit vaccine carriers","volume":"4","author":"Vartak","year":"2016","journal-title":"Vaccines"},{"key":"B23","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jaci.2017.07.001","article-title":"Promising approaches for the treatment and prevention of viral respiratory illnesses","volume":"140","author":"Papadopoulos","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"C8","DOI":"10.1016\/j.vaccine.2008.04.011","article-title":"Vaccination and antigenic drift in influenza","volume":"26","author":"Boni","year":"2008","journal-title":"Vaccine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1039\/a907827d","article-title":"Nanobiotechnology and its role in the development of new analytical devices","volume":"125","author":"Laval","year":"2000","journal-title":"Analyst"},{"key":"B26","first-page":"1249","article-title":"Green synthesis of nanoparticles: their advantages and disadvantages","author":"Parveen","year":"2016","journal-title":"5th National Conference on Thermophysical Properties: (Nctp-09)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1601556","DOI":"10.1126\/sciadv.1601556","article-title":"Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation","volume":"3","author":"Schneider","year":"2017","journal-title":"Sci Adv."},{"key":"B28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41524-017-0050-y","article-title":"Theory, simulations and the design of functionalized nanoparticles for biomedical applications: a soft matter perspective","volume":"3","author":"Angioletti-Uberti","year":"2017","journal-title":"NPJ Comput Mater."},{"key":"B29","doi-asserted-by":"publisher","first-page":"11109","DOI":"10.1021\/acs.chemrev.5b00109","article-title":"Synthetic nanoparticles for vaccines and immunotherapy","volume":"115","author":"Irvine","year":"2015","journal-title":"Chem Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1039\/C5TB01825K","article-title":"Materials design at the interface of nanoparticles and innate immunity","volume":"4","author":"Szeto","year":"2016","journal-title":"J Mater Chem B"},{"key":"B31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1039\/C5BM00360A","article-title":"Nanostructures for protein drug delivery","volume":"4","author":"Pachioni-Vasconcelos Jde","year":"2016","journal-title":"Biomater Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.vaccine.2011.10.105","article-title":"PLGA\/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.)","volume":"30","author":"Fredriksen","year":"2012","journal-title":"Vaccine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.1016\/j.vaccine.2012.08.023","article-title":"Nanovaccinology: the next generation of vaccines meets 21st century materials science and engineering","volume":"30","author":"Mamo","year":"2012","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.4161\/hv.29589","article-title":"Applications of nanomaterials as vaccine adjuvants","volume":"10","author":"Zhu","year":"2014","journal-title":"Hum Vaccin Immunother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1\u03b2-dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nri2725","article-title":"NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?","volume":"10","author":"Tschopp","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nm.2999","article-title":"Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth","volume":"19","author":"Bruchard","year":"2012","journal-title":"Nat Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.redox.2015.01.008","article-title":"NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases","volume":"4","author":"Abderrazak","year":"2015","journal-title":"Redox Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"9035","DOI":"10.1073\/pnas.0803933105","article-title":"The Nalp3 inflammasome is essential for the development of silicosis","volume":"105","author":"Cassel","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B41","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2","volume":"9","author":"Halle","year":"2008","journal-title":"Nat Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1073\/pnas.0804897106","article-title":"Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome","volume":"106","author":"Sharp","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B43","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.4049\/jimmunol.1002843","article-title":"Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway","volume":"186","author":"Niemi","year":"2011","journal-title":"J Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/ncomms1754","article-title":"Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris","volume":"3","author":"Scharf","year":"2012","journal-title":"Nat Commun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/wnan.45","article-title":"Nanoparticle vaccines against respiratory viruses","volume":"1","author":"Adair","year":"2009","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e84097","DOI":"10.1371\/journal.pone.0084097","article-title":"Characteristics of nasal-associated lymphoid tissue (NALT) and nasal absorption capacity in chicken","volume":"8","author":"Kang","year":"2014","journal-title":"PLoS ONE"},{"key":"B48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4155\/tde-2016-0068","article-title":"Intranasal delivery of nanoparticle-based vaccines","volume":"8","author":"Marasini","year":"2017","journal-title":"Ther Deliv."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.4049\/jimmunol.168.4.1796","article-title":"Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses","volume":"168","author":"Zuercher","year":"2002","journal-title":"J Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1146\/annurev.bi.52.070183.002343","article-title":"The gene structure and replication of influenza virus","volume":"52","author":"Lamb","year":"1983","journal-title":"Annu Rev Biochem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1128\/CMR.16.2.242-264.2003","article-title":"Parainfluenza viruses","volume":"16","author":"Henrickson","year":"2003","journal-title":"Clin Microbiol Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"10209","DOI":"10.1073\/pnas.0712144105","article-title":"Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2","volume":"105","author":"Utley","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B53","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1042\/BJ20100766","article-title":"Unity and diversity in the human adenoviruses: exploiting alternative entry pathways for gene therapy","volume":"431","author":"Hall","year":"2010","journal-title":"Biochem J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3390\/vaccines5010006","article-title":"Harnessing nanoparticles for immunomodulation and vaccines","volume":"5","author":"Gomes","year":"2017","journal-title":"Vaccines"},{"key":"B55","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1002\/adma.201302737","article-title":"Nanoparticles mimicking viral surface topography for enhanced cellular delivery","volume":"25","author":"Niu","year":"2013","journal-title":"Adv Mater."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coche.2017.11.001","article-title":"The exciting potential of modular nanoparticles for rapid development of highly effective vaccines","volume":"19","author":"Fogarty","year":"2018","journal-title":"Curr Opin Chem Eng."},{"key":"B57","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1073\/pnas.1422923112","article-title":"Controlled analysis of nanoparticle charge on mucosal and systemic antibody responses following pulmonary immunization","volume":"112","author":"Fromen","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B58","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.biomaterials.2014.10.043","article-title":"Near-infrared labeled, ovalbumin loaded polymeric nanoparticles based on a hydrophilic polyester as model vaccine: In vivo tracking and evaluation of antigen-specific CD8(+) T cell immune response","volume":"37","author":"Rahimian","year":"2015","journal-title":"Biomaterials"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e01844","DOI":"10.1128\/JVI.01844-16","article-title":"Adjuvanting a simian immunodeficiency virus vaccine with toll-like receptor ligands encapsulated in nanoparticles induces persistent antibody responses and enhanced protection in TRIM5alpha restrictive macaques","volume":"91","author":"Kasturi","year":"2017","journal-title":"J Virol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3389\/fimmu.2018.00230","article-title":"Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance","volume":"9","author":"Kishimoto","year":"2018","journal-title":"Front Immunol."},{"key":"B61","first-page":"265","article-title":"Nanoencapsulation for drug delivery","volume":"13","author":"Kumari","year":"2014","journal-title":"EXCLI J."},{"key":"B62","doi-asserted-by":"publisher","first-page":"7897","DOI":"10.1016\/j.vaccine.2010.09.077","article-title":"Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation","volume":"28","author":"Hirosue","year":"2010","journal-title":"Vaccine"},{"key":"B63","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.2147\/IJN.S140789","article-title":"Nanoparticle orientationally displayed antigen epitopes improve neutralizing antibody level in a model of porcine circovirus type 2","volume":"12","author":"Ding","year":"2017","journal-title":"Int J Nanomed."},{"key":"B64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.antiviral.2017.01.021","article-title":"Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses","volume":"141","author":"Tao","year":"2017","journal-title":"Antiviral Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.09.031","article-title":"Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers","volume":"149","author":"Mora-Solano","year":"2017","journal-title":"Biomaterials"},{"key":"B66","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.biotechadv.2017.05.002","article-title":"Harnessing self-assembled peptide nanoparticles in epitope vaccine design","volume":"35","author":"Negahdaripour","year":"2017","journal-title":"Biotechnol Adv."},{"key":"B67","doi-asserted-by":"publisher","first-page":"19547","DOI":"10.1039\/C8NR05948A","article-title":"Engineering and evaluation of amyloid assemblies as a nanovaccine against the Chikungunya virus","volume":"10","author":"Babych","year":"2018","journal-title":"Nanoscale"},{"key":"B68","doi-asserted-by":"publisher","first-page":"6276","DOI":"10.1016\/j.vaccine.2009.04.074","article-title":"PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants","volume":"27","author":"Ichinohe","year":"2009","journal-title":"Vaccine"},{"key":"B69","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1128\/IAI.72.1.238-246.2004","article-title":"Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis","volume":"72","author":"Chen","year":"2004","journal-title":"Infect Immun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.femsim.2005.02.009","article-title":"Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis","volume":"45","author":"Giri","year":"2005","journal-title":"FEMS Immunol Med Microbiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1128\/CVI.00250-09","article-title":"Intranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategies","volume":"17","author":"Mapletoft","year":"2010","journal-title":"Clin Vaccine Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11259-011-9484-8","article-title":"Mucosal immunization provides better protection than subcutaneous immunization against Pasteurella multocida (B:2) in mice preimmunized with the outer membrane proteins","volume":"35","author":"Kharb","year":"2011","journal-title":"Vet Res Commun."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e0194614","DOI":"10.1371\/journal.pone.0194614","article-title":"Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge","volume":"13","author":"Mccormick","year":"2018","journal-title":"PLoS ONE"},{"key":"B75","first-page":"729","article-title":"Advantages of intranasal vaccination and considerations on device selection","volume":"71","author":"Birkhoff","year":"2009","journal-title":"Indian J Pharmaceut Sci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1080\/21645515.2017.1356952","article-title":"Developments in the formulation and delivery of spray dried vaccines","volume":"13","author":"Kanojia","year":"2017","journal-title":"Hum Vaccin Immunother."},{"key":"B77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7774\/cevr.2017.6.1.15","article-title":"The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants","volume":"6","author":"Kim","year":"2017","journal-title":"Clin Exp Vaccine Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1021\/nn5062029","article-title":"Nanoparticle-based immunotherapy for cancer","volume":"9","author":"Shao","year":"2015","journal-title":"ACS Nano."},{"key":"B79","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.nano.2016.08.028","article-title":"Nanoparticle-based B-cell targeting vaccines: tailoring of humoral immune responses by functionalization with different TLR-ligands","volume":"13","author":"Zilker","year":"2017","journal-title":"Nanomedicine"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1704408","DOI":"10.1002\/adma.201704408","article-title":"Antigen-directed fabrication of a multifunctional nanovaccine with ultrahigh antigen loading efficiency for tumor photothermal-immunotherapy","volume":"30","author":"Pan","year":"2018","journal-title":"Adv Mater."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s11095-014-1419-y","article-title":"Biomaterials for nanoparticle vaccine delivery systems","volume":"31","author":"Sahdev","year":"2014","journal-title":"Pharmaceut Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12917-015-0481-y","article-title":"Comparing the immune response to a novel intranasal nanoparticle PLGA vaccine and a commercial BPI3V vaccine in dairy calves","volume":"11","author":"Mansoor","year":"2015","journal-title":"BMC Vet Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jconrel.2016.12.039","article-title":"Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs","volume":"247","author":"Dhakal","year":"2017","journal-title":"J Control Release"},{"key":"B84","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1016\/j.vaccine.2009.07.037","article-title":"Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice","volume":"27","author":"Okamoto","year":"2009","journal-title":"Vaccine"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/jmv.24253","article-title":"Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration","volume":"87","author":"Liu","year":"2015","journal-title":"J Med Virol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1208\/s12249-013-0058-7","article-title":"Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine","volume":"15","author":"Sawaengsak","year":"2014","journal-title":"AAPS PharmSciTech."},{"key":"B87","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3389\/fimmu.2018.00934","article-title":"Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle delivery in pigs","volume":"9","author":"Dhakal","year":"2018","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1016\/j.vaccine.2018.02.072","article-title":"Nasal vaccination with r4M2e","volume":"36","author":"Dabaghian","year":"2018","journal-title":"Vaccine"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/nbt.3371","article-title":"In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity","volume":"33","author":"Lynn","year":"2015","journal-title":"Nat Biotechnol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1021\/acs.bioconjchem.6b00370","article-title":"Thermoresponsive polymer nanoparticles Co-deliver RSV F Trimers with a TLR-7\/8 Adjuvant","volume":"27","author":"Francica","year":"2016","journal-title":"Bioconjug Chem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s11095-008-9760-7","article-title":"Polymer chemistry influences monocytic uptake of polyanhydride nanospheres","volume":"26","author":"Ulery","year":"2009","journal-title":"Pharm Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1038\/s41598-018-21292-2","article-title":"Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf","volume":"8","author":"Mcgill","year":"2018","journal-title":"Sci Rep."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e1766","DOI":"10.1371\/journal.pone.0001766","article-title":"Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus","volume":"3","author":"Roux","year":"2008","journal-title":"PLoS ONE"},{"key":"B94","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.nano.2016.08.006","article-title":"RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine","volume":"13","author":"Herve","year":"2017","journal-title":"Nanomedicine"},{"key":"B95","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1128\/JVI.01141-13","article-title":"A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2","volume":"88","author":"Herve","year":"2014","journal-title":"J Virol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e1703207","DOI":"10.1002\/smll.201703207","article-title":"Intranasal nanovaccine confers homo- and hetero-subtypic influenza protection","volume":"14","author":"Qi","year":"2018","journal-title":"Small"},{"key":"B97","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jconrel.2018.04.031","article-title":"Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8(+) T cell responses","volume":"282","author":"Si","year":"2018","journal-title":"J Control Release"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1128\/JVI.02052-06","article-title":"Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus","volume":"81","author":"Quan","year":"2007","journal-title":"J Virol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"e0190868","DOI":"10.1371\/journal.pone.0190868","article-title":"Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS ONE"},{"key":"B100","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/abbs\/gmw118","article-title":"Virus-like particle vaccine by intranasal vaccination elicits protective immunity against respiratory syncytial viral infection in mice","volume":"49","author":"Cai","year":"2017","journal-title":"Acta Biochim Biophys Sin."},{"key":"B101","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/mi.2008.59","article-title":"Pulmonary delivery of ISCOMATRIX influenza vaccine induces both systemic and mucosal immunity with antigen dose sparing","volume":"1","author":"Wee","year":"2008","journal-title":"Mucosal Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0264-410X(02)00545-5","article-title":"Intranasal vaccination with ISCOMATRIX\u00ae adjuvanted influenza vaccine","volume":"21","author":"Coulter","year":"2003","journal-title":"Vaccine"},{"key":"B103","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/mi.2010.50","article-title":"Multistrain influenza protection induced by a nanoparticulate mucosal immunotherapeutic","volume":"4","author":"Tai","year":"2011","journal-title":"Mucosal Immunol."},{"key":"B104","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1381612822666161021104239","article-title":"Molecularly engineered polymer-based systems in drug delivery and regenerative medicine","volume":"23","author":"Piluso","year":"2017","journal-title":"Curr Pharm Des."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem Soc Rev."},{"key":"B106","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1039\/c3tb20191k","article-title":"Polymeric theranostics: using polymer-based systems for simultaneous imaging and therapy","volume":"1","author":"Krasia-Christoforou","year":"2013","journal-title":"J Mater Chem B"},{"key":"B107","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.progpolymsci.2016.05.005","article-title":"Polymeric nanostructured materials for biomedical applications","volume":"60","author":"Tang","year":"2016","journal-title":"Progress Polymer Sci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.addr.2010.10.008","article-title":"PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect","volume":"63","author":"Acharya","year":"2011","journal-title":"Adv Drug Deliv Rev."},{"key":"B109","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1477-3155-9-55","article-title":"Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines","volume":"9","author":"Mahapatro","year":"2011","journal-title":"J Nanobiotechnol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J Control Release"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Hum Vaccin Immunother."},{"key":"B112","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.it.2015.05.007","article-title":"Harnessing nanoparticles for immune modulation","volume":"36","author":"Getts","year":"2015","journal-title":"Trends Immunol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-bioeng-071811-150054","article-title":"Mucosal vaccine design and delivery","volume":"14","author":"Woodrow","year":"2012","journal-title":"Annu Rev Biomed Eng."},{"key":"B114","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.nano.2013.04.003","article-title":"PLGA nanoparticles loaded with KMP-11 stimulate innate immunity and induce the killing of Leishmania","volume":"9","author":"Santos","year":"2013","journal-title":"Nanomedicine"},{"key":"B115","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.addr.2008.09.005","article-title":"Nanoparticles for nasal vaccination","volume":"61","author":"Csaba","year":"2009","journal-title":"Adv Drug Deliv Rev."},{"key":"B116","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.carbpol.2014.04.025","article-title":"Effect and mechanisms of curdlan sulfate on inhibiting HBV infection and acting as an HB vaccine adjuvant","volume":"110","author":"Li","year":"2014","journal-title":"Carbohydr Polym."},{"key":"B117","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.carbpol.2013.10.078","article-title":"Preparation and in vitro immunomodulatory effect of curdlan sulfate","volume":"102","author":"Li","year":"2014","journal-title":"Carbohydr Polym."},{"key":"B118","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s10924-016-0865-5","article-title":"Chitin and chitosan: structure, properties and applications in biomedical engineering","volume":"25","author":"Islam","year":"2016","journal-title":"J Polym Environ."},{"key":"B119","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.2217\/nnm-2016-0291","article-title":"Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery","volume":"11","author":"Marasini","year":"2016","journal-title":"Nanomedicine"},{"key":"B120","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3389\/fcimb.2017.00445","article-title":"Intranasal vaccination with mannosylated chitosan formulated DNA vaccine enables robust IgA and cellular response induction in the lungs of mice and improves protection against pulmonary mycobacterial challenge","volume":"7","author":"Wu","year":"2017","journal-title":"Front Cell Infect Microbiol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.2147\/IJN.S158536","article-title":"Curdlan sulfate-O-linked quaternized chitosan nanoparticles: potential adjuvants to improve the immunogenicity of exogenous antigens via intranasal vaccination","volume":"13","author":"Zhang","year":"2018","journal-title":"Int J Nanomed."},{"key":"B122","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1208\/s12248-014-9699-z","article-title":"Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles","volume":"17","author":"Vela-Ramirez","year":"2015","journal-title":"AAPS J."},{"key":"B123","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1016\/j.actbio.2010.01.040","article-title":"Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens","volume":"6","author":"Carrillo-Conde","year":"2010","journal-title":"Acta Biomater."},{"key":"B124","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1021\/mp2004059","article-title":"Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen","volume":"9","author":"Petersen","year":"2012","journal-title":"Mol Pharm."},{"key":"B125","doi-asserted-by":"publisher","first-page":"e17642","DOI":"10.1371\/journal.pone.0017642","article-title":"Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases","volume":"6","author":"Ulery","year":"2011","journal-title":"PLoS ONE"},{"key":"B126","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/srep00198","article-title":"Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants","volume":"1","author":"Ulery","year":"2011","journal-title":"Sci Rep."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/adhm.201300525","article-title":"Lung deposition and cellular uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours","volume":"3","author":"Ross","year":"2014","journal-title":"Adv Healthc Mater."},{"key":"B128","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.drudis.2008.06.016","article-title":"Virus-sized vaccine delivery systems","volume":"13","author":"Scheerlinck","year":"2008","journal-title":"Drug Discov Today"},{"key":"B129","first-page":"53","article-title":"Virus-like particles for antigen delivery at mucosal surfaces","volume-title":"Mucosal Vaccines: Modern Concepts, Strategies, and Challenges.","author":"Schneider-Ohrum","year":"2012"},{"key":"B130","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/349541a0","article-title":"Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts","volume":"349","author":"Lawson","year":"1991","journal-title":"Nature"},{"key":"B131","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.nano.2006.07.009","article-title":"Adaptations of nanoscale viruses and other protein cages for medical applications","volume":"2","author":"Lee","year":"2006","journal-title":"Nanomedicine"},{"key":"B132","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/ind.2006.2.143","article-title":"Ferritin nanoparticle technology","volume":"2","author":"Li","year":"2006","journal-title":"Ind Biotechnol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.bbagen.2010.03.005","article-title":"Ferritin in the field of nanodevices","volume":"1800","author":"Yamashita","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B134","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jmb.2012.05.032","article-title":"Crystal structure of the coat protein of the flexible filamentous papaya mosaic virus","volume":"422","author":"Yang","year":"2012","journal-title":"J Mol Biol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1477-3155-11-10","article-title":"Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP","volume":"11","author":"Babin","year":"2013","journal-title":"J Nanobiotechnol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"B137","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"key":"B138","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.csbj.2015.11.001","article-title":"Self-assembling protein nanoparticles in the design of vaccines","volume":"14","author":"Lopez-Sagaseta","year":"2016","journal-title":"Comput Struct Biotechnol J."},{"key":"B139","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4049\/jimmunol.198.Supp.225.5","article-title":"Spike nanoparticle and recombinant adenovirus 5 vaccines induce specific antibodies against the Middle East respiratory syndrome coronavirus (MERS-CoV)","volume":"198","author":"Park","year":"2017","journal-title":"J Immunol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12951-017-0289-y","article-title":"A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling","volume":"15","author":"Therien","year":"2017","journal-title":"J Nanobiotechnol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41467-017-02725-4","article-title":"Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses","volume":"9","author":"Deng","year":"2018","journal-title":"Nat Commun."},{"key":"B142","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"},{"key":"B143","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.nano.2013.02.009","article-title":"Induction of innate immunity in lungs with virus-like nanoparticles leads to protection against influenza and Streptococcus pneumoniae challenge","volume":"9","author":"Mathieu","year":"2013","journal-title":"Nanomedicine"},{"key":"B144","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12033-012-9598-4","article-title":"Construction and characterization of virus-like particles: a review","volume":"53","author":"Zeltins","year":"2013","journal-title":"Mol Biotechnol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.tibtech.2013.09.002","article-title":"Virus-like particle-based human vaccines: quality assessment based on structural and functional properties","volume":"31","author":"Zhao","year":"2013","journal-title":"Trends Biotechnol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.smim.2017.08.014","article-title":"Major findings and recent advances in virus-like particle (VLP)-based vaccines","volume":"34","author":"Mohsen","year":"2017","journal-title":"Semin Immunol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/03639040802192806","article-title":"Rational design of a stable, freeze-dried virus-like particle-based vaccine formulation","volume":"35","author":"Lang","year":"2009","journal-title":"Drug Dev Ind Pharm."},{"key":"B148","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1039\/C5CS00699F","article-title":"In vivo degeneration and the fate of inorganic nanoparticles","volume":"45","author":"Feliu","year":"2016","journal-title":"Chem Soc Rev."},{"key":"B149","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mattod.2015.07.004","article-title":"Inorganic nanoparticles for biomedicine: where materials scientists meet medical research","volume":"19","author":"Giner-Casares","year":"2016","journal-title":"Mater Today"},{"key":"B150","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.molimm.2008.08.277","article-title":"Peptides conjugated to gold nanoparticles induce macrophage activation","volume":"46","author":"Bastus","year":"2009","journal-title":"Mol Immunol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jconrel.2017.04.024","article-title":"Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses","volume":"256","author":"Kang","year":"2017","journal-title":"J Control Release"},{"key":"B152","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1021\/cm049532v","article-title":"A simple large-scale synthesis of nearly monodisperse gold and silver nanoparticles with adjustable sizes and with exchangeable surfactants","volume":"16","author":"Hiramatsu","year":"2004","journal-title":"Chem Mater."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1021\/ar200260p","article-title":"The chemistry of the sulfur-gold interface: in search of a unified model","volume":"45","author":"Pensa","year":"2012","journal-title":"Acc Chem Res."},{"key":"B154","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fchem.2016.00008","article-title":"Surface analysis of gold nanoparticles functionalized with thiol-modified glucose SAMs for biosensor applications","volume":"4","author":"Spampinato","year":"2016","journal-title":"Front Chem."},{"key":"B155","doi-asserted-by":"publisher","first-page":"23403","DOI":"10.1039\/C8CP02054J","article-title":"Tuning the size of gold nanoparticles produced by multiple filamentation of femtosecond laser pulses in aqueous solutions","volume":"20","author":"Belmouaddine","year":"2018","journal-title":"Phys Chem Chem Phys."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.nano.2018.03.007","article-title":"Gold nanoparticles conjugating recombinant influenza hemagglutinin trimers and flagellin enhanced mucosal cellular immunity","volume":"14","author":"Wang","year":"2018","journal-title":"Nanomedicine"},{"key":"B157","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1517\/17425247.2014.891582","article-title":"Gold nanoparticle conjugates: recent advances toward clinical applications","volume":"11","author":"Cao-Milan","year":"2014","journal-title":"Expert Opin Drug Deliv."},{"key":"B158","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.sbsr.2016.04.002","article-title":"Various methods of gold nanoparticles (GNPs) conjugation to antibodies","volume":"9","author":"Jazayeri","year":"2016","journal-title":"Sens Bio Sensing Res."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1586\/14760584.2015.1064772","article-title":"Gold nanoparticles and vaccine development","volume":"14","author":"Salazar-Gonzalez","year":"2015","journal-title":"Exp Rev Vaccines"},{"key":"B160","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fimmu.2017.00239","article-title":"Role of metallic nanoparticles in vaccinology: implications for infectious disease vaccine development","volume":"8","author":"Marques Neto","year":"2017","journal-title":"Front Immunol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2217\/nnm.13.58","article-title":"Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza a virus","volume":"9","author":"Tao","year":"2014","journal-title":"Nanomedicine"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1039\/b806051g","article-title":"Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity","volume":"38","author":"Boisselier","year":"2009","journal-title":"Chem Soc Rev."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00022\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T03:59:32Z","timestamp":1694577572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00022\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":162,"alternative-id":["10.3389\/fimmu.2019.00022"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00022","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"article-number":"22"}}